Abstract
Cancer is characterized as a serious public health problem. Particularly, bladder cancer has a high cost to health system, especially given the need for routine clinical monitoring (urine cytology and cystoscopy) and high recurrence rate. Due to the complexity of biological systems, little is known about the molecular mechanisms responsible for urothelial carcinomas. The literature shows …